Breaking News

Small-Cap Momentum Continues

By Banc De BinaryStock MarketsMar 12, 2014 10:22AM ET
Small-Cap Momentum Continues
By Banc De Binary   |  Mar 12, 2014 10:22AM ET
Saved. See Saved Items.
This article has already been saved in your Saved Items

The momentum established by small-cap stocks in 2013 is supporting a continuation in the solid performance of small caps as 2014 unfolds. As expected, the Russell Index shows small caps to be outperforming large caps through the beginning of 2014.

The Russell Developed Europe Small Cap Index presents a January 2014 picture of 2X the growth of the Europe Large Cap Index, 4.2% against 2.1%. Likewise the Russell Global Small Cap Index exhibits in excess of twice the percentage of Global Large Cap growth, 2.5% against 1.2%.

Various small-cap equities are expected to offer continued substantial gain with lower risk than that associated with large-cap equities. The recommended small caps that led the 2013 market in high performance and continue in that strong upward trend in the current year, include Realogy (RLGY), WebMD (WBMD), Cepheid (CPHD) and Horace Mann Educators (HMN).

Realogy (RLGY)
With subsidiaries at the top of the global real estate industry, Realogy experienced a phenomenal 21.2% rise in 2013 third-quarter earnings. The end product of that increase was $1.55 billion. Coldwell Banker, Sotheby’s International Realty, ERA, Coldwell Banker Commercial, Better homes and Gardens Real Estate, Century 21, Corcoran Group and CitiHabitats are its subsidiaries, with branches in over 100 countries. Realogy projects 2014 growth to be in the area of 17% to 19%.

The company is composed of four main departments: Relocation Services, Real Estate Franchise Services, Company Owned Real Estate Brokerage Services and Title and Settlement Services. RLGY provides lenders with a complete line of foreclosed home transactions as well as tending to every aspect of the buyer/seller real estate market, all within the brokerage services segment of the company. By the end of 2012, Realogy had 13,600 franchised offices spanning the entire world, with a total of 238,900 sales associates.


Previously known as Domus Holdings Corporation, in September 2012 the company acquired its current name Realogy Holdings Corporation. The 2013 net income of this entity was $320 million, an increase of $28 million over the net earnings in 2012.

As the economies of the developed regions such as Europe, Japan and the US continue to proceed in a pattern of healthy monetary growth, market analysts predict a 2014 global economic recovery. GDP increases lead to sharp and sustained surges in real estate sales. The perception of an ongoing worldwide economic recovery further enhances and maintains the rise in home sale closings.

The price of Realogy stock as of 02/26/2014 was $46.65 on a volume of 3.8 million, up $1.43 (3.1%) from the previous close of $45.22. The current earnings per share is $3.26.

As the parent company of three enormous entities, Realogy was a participant in 26% of the 2012 real estate firm transactions that took place around the world. The expectation is that this company is poised to continue its growth in 2014.

Resilience is the name of the game for WebMD Health Corporation. Following a downturn in 2012, WebMD reconstructed a winning format. The company diversified its sources of income, effectuated a major cost-cutting program and overhauled its advertising agenda. The 2013 result was a 144% rise in the stock price. Market analysts project a comparable 131% increase in 2014.

As of 02/26/2014, the price of WebMD was $45.49, up $0.33 from the previous close, on a volume of $1.39 million. In terms of income, the company continues to dig itself out from its 2012 devastation. WebMD expects to achieve a profitable outcome in 2014.

WebMD is an investment opportunity sailing forward on the tailwind of Obamacare. The health corporation is the access initiation for greater than five million members of the Blue Cross/Blue Shield Benefit Plan.

Revenue and per-share earnings both exceeded analyst projects. As to dividends, the expectation for fourth-quarter 2013 had been 18 cents per share; in reality the earnings totaled 23 to 25 cents a share. Sales are expected to reach $130 million to $133 million by the end of the first quarter 2014. The projection had been $128.7 million. The company revenue is running approximately 10% higher when compared to the previous year’s quarter.

Cepheid (CPHD)
FDA approval often brings with it the threshold of major profits. That approval was garnered by Cepheid in June 2013 in regard to its Xpert MRSA/SA BC test. This molecular diagnostic company developed its BC test for the purpose of detecting sepsis infections in hospital patients. Not surprisingly, the third-quarter 2013 earnings saw a year-over-year increase of 24%.

Cepheid is a $2.7 billion entity that has invented the GeneXpert platform. This system is the most-used program available in the molecular diagnostic field. The CPHD stock rose 25% during the second half of 2013. As of 02/26/2014, the price per share was $54.60, down $0.21 (-0.38%) from the previous close. The current recommendations for Cepheid Inc. at MSN MONEY includes a ‘Strong Buy’ as well as a ‘Hold’.

Horace Mann Educators Corp. (HMN).

This education-oriented insurance company has existed for 69 years. 2013 third-quarter assets totaled $8.5 billion, a rise of 4.9% over the same quarter of the previous year. Its clientele includes public grade-school staff throughout the U.S. A total of 3.8 million current and retired school administrators and teachers are covered by HMN. Almost half a million students in higher education are future teachers.
Horace Mann Educators
Horace Mann Educators

Horace Mann is the largest U.S. educators’ multiline insurance enterprise. Situated throughout the nation, 800 distribution centers provide annuities along with home, auto and life insurance.

While the expected growth of 14% over the next seven years is far from large, the stock of this profitable company carries a low risk. Horace Mann Educators is a recommended small-cap entity, as it is a relatively safe investment and lends itself well to the aim of portfolio diversification.

Investors profit from small-cap companies that follow a strong upward trend and have proven to be resilient, pro-active in the adaptation of industry advancements and diversified in their growth strategies. Such entities are the high-performance leaders in the market.

Small-Cap Momentum Continues

Related Articles

Small-Cap Momentum Continues

Add a Comment

Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

Are you sure you want to delete this chart?
Write your thoughts here
Replace the attached chart with a new chart ?
Post also to:
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Are you sure you want to delete this chart?
Replace the attached chart with a new chart ?
Post 1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn`t bear any responsibility for any trading losses you might incur as a result of using this data.

Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Continue with Google
Sign up with Email